Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about Robert Barrow Recent news which mentions Robert Barrow MindMed Calls FDA Experts To Validate LSD Drug Development Strategy May 25, 2023 Tickers MNMD Tags LSD program Penny Stocks Psychedelic/Assisted Therapies From Benzinga MindMed's Q3 2022 Financials & Business, Setting The Stage For Phase 3 Trials November 11, 2022 Tickers MNMD Tags Robert Barrow Markets MNMD From Benzinga MindMed's First Patient Dosing Clinical Trial With LSD For Treatment Of Generalized Anxiety Disorder August 25, 2022 Tickers MNMD Tags Penny Stocks LSD MindMed From Benzinga MindMed: Financial And Business Results For Q2 2022, Management And Pipeline Changes August 12, 2022 Tickers MNMD OPNT Tags MNMD MM/120 Earnings From Benzinga Cannabis Movers & Shakers: Mind Medicine, 22nd Century Group, Grown Rogue International May 24, 2022 Tickers GRUSF HALO MNMD XXII Tags Markets Robert Barrow Obie Strickler From Benzinga MindMed Appoints Schond L. Greenway As CFO May 23, 2022 Tickers AVTX HALO MEOBF MNMD Tags Schond L/ Greenway MNMD News From Benzinga From Pharma To Psychedelics, Robert Barrow, CEO Of MindMed: Meet Our Speakers April 04, 2022 Tickers MNMD Tags MindMed Benzinga Penny Stocks From Benzinga MindMed Converts Shares To Have A Single Class February 23, 2022 Tickers MNMD Tags News Small Cap MNMD From Benzinga Cybin, MindMed, And Field Trip Health Headline PSYC's First CEO Round Table Event February 14, 2022 Tickers CYBN FTRP MMDCF PSYC Tags Markets Robert Barrow PSYC From Benzinga MindMed Shares Soar After FDA Approves First Commercial Clinical Trial On LSD In 40 Years January 26, 2022 Tickers MNMD Tags Cannabis Market News Benzinga From Benzinga Cannabis Movers & Shakers: MindMed, Halo Collective, Item 9, PSYC, Flora Growth January 10, 2022 Tickers AMZN CXXIF FLGC HCANF Tags Movers & Shakers HCANF News From Benzinga MindMed Completes Phase 1 Clinical Trial Of Non-Hallucinogenic Proprietary Derivative Of Ibogaine January 04, 2022 Tickers MNMD Tags MNMD Ibogaine trial psychedelics From Benzinga Cannabis Movers & Shakers: MindMed & Trulieve Management Shake-Ups, Credex Corp & CapStone Bolster Leadership Teams December 29, 2021 Tickers CRDX CURLF MNMD TCNNF Tags Benzinga CURLF Market News From Benzinga MindMed Shares Update On Phase 2b Trials of LSD For Treating Generalized Anxiety Disorder December 22, 2021 Tickers MNMD Tags Robert Barrow Market News Benzinga From Benzinga MindMed Advances Phase 2a LSD Microdose Trial For Adult ADHD December 17, 2021 Tickers MNMD Tags Small Cap Biotech Market News From Benzinga MindMed Names Robert Barrow As CEO & Director, Announces Management Shake-Ups December 14, 2021 Tickers CRLBF MNMD Tags Benzinga Penny Stocks Cannabis From Benzinga EXCLUSIVE: MindMed CEO Rob Barrow On Growth Aspirations, Development Pipeline December 10, 2021 Tickers MNMD NDAQ Tags MNMD Small Cap Interview From Benzinga Cannabis Movers & Shakers: Mind Medicine, Avant Brands, Delic, Agrify, Ascend Wellness, Pure Beauty November 11, 2021 Tickers AAWH MMNFF MNMD Tags MNMD General AAWH From Benzinga Cannabis Movers & Shakers: Leafly Holdings, Linneo Health, Flowhub, MindMed October 04, 2021 Tickers BAC CGC CRARF CS Tags Small Cap CS CRARF From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.